Fig. 9From: Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinomaAssociations of risk score with tumor mutational burden and immune checkpoint genes. A Risk score did not correlate strongly with tumor mutational burden. B-O Risk score was significantly associated with multiple immune checkpoint genesBack to article page